BSEM (BioStem Technologies) Interest Expense: $-0.1 Mil (TTM As of Sep. 2025)


BSEM BioStem Technologies Inc BSEM
53 GF Score
Price $3.24
GF Value $141.51
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is BioStem Technologies Interest Expense?

BioStem Technologies BSEM +0.62% 53 Interest Expense is $-0.1 Mil as of Sep. 2025. GuruFocus rates BSEM with a GF Score™ of 53/100 and a GF Value™ of $141.51 (Possible Value Trap). The stock has 3 warning signs investors should review.

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. BioStem Technologies's interest expense for the three months ended in Sep. 2025 was $ 0.0 Mil. Its interest expense for the trailing twelve months (TTM) ended in Sep. 2025 was $-0.1 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. BioStem Technologies's Operating Income for the three months ended in Sep. 2025 was $ 1.4 Mil. BioStem Technologies's Interest Expense for the three months ended in Sep. 2025 was $ 0.0 Mil. GuruFocus does not calculate BioStem Technologies's interest coverage with the available data. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioStem Technologies  (OTCPK:BSEM) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

BioStem Technologies's Interest Expense for the three months ended in Sep. 2025 was $0.0 Mil. Its Operating Income for the three months ended in Sep. 2025 was $1.4 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Sep. 2025 was $0.2 Mil.

BioStem Technologies's Interest Coverage for the quarter that ended in Sep. 2025 is calculated as

GuruFocus does not calculate BioStem Technologies's interest coverage with the available data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Good Sign:

Ben Graham prefers companies' interest coverage to be at least 5. BioStem Technologies Inc has enough cash to cover all of its debt. Its financial situation is stable.

BioStem Technologies Interest Expense Historical Data

* Premium members only.

The historical data trend for BioStem Technologies's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioStem Technologies Interest Expense Chart

BioStem Technologies Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Interest Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.53 -0.53 -0.47 -0.70 -0.59

BioStem Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Sep21 Dec21 Mar22 Sep22 Dec22 Mar23 Sep23 Dec23 Sep24 Dec24 Sep25
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.20 -0.24 -0.14 -0.07 0.00
BSEM
53GF Score
BioStem Technologies Inc BSEM
Interest Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

BioStem Technologies Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Sep. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.1 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Interest Expense →
What does a Interest Expense of $-0.1 Mil mean?
BioStem Technologies (BSEM) has a Interest Expense of $-0.1 Mil as of Sep. 2025. Interest Expense is the amount a company pays on its long-term debt. View historical data on BioStem Technologies and its competitors.
Is BioStem Technologies' Interest Expense too high?
BioStem Technologies' current Interest Expense is $-0.1 Mil. Overall, BioStem Technologies has a GF Score™ of 53/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does BioStem Technologies' Interest Expense compare to XLO and TCRX?
BioStem Technologies' Interest Expense of $-0.1 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Interest Expense for a Biotechnology company?
A good Interest Expense depends on the Biotechnology industry context. However, Interest Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Interest Expense mean?
A high Interest Expense can signal that a stock is expensive relative to its fundamentals. Interest Expense is the amount a company pays on its long-term debt. View historical data on BioStem Technologies and its competitors. BioStem Technologies's current Interest Expense is $-0.1 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BioStem Technologies stock overvalued right now?
Based on GuruFocus' analysis, BioStem Technologies (BSEM) is currently considered Possible Value Trap. The stock's GF Value™ is $141.51, compared to a current price of $3.24 — trading 97.7% below its estimated fair value. The current Interest Expense is $-0.1 Mil. BioStem Technologies' overall GF Score™ is 53/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Interest Expense calculated?
Interest Expense is calculated from a company's financial statements. For BioStem Technologies (BSEM), the current Interest Expense is $-0.1 Mil as of Sep. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is BioStem Technologies (BSEM) Overvalued in 2026?

Based on GuruFocus' analysis, BioStem Technologies stock appears to be undervalued. The current stock price of $3.24 is trading 97.7% below its estimated GF Value™ of $141.51. GuruFocus considers BioStem Technologies to be Possible Value Trap.

Key valuation signals for BSEM:

  • Interest Expense: $-0.1 Mil
  • GF Value™: $141.51 vs. price of $3.24 (97.7% below fair value)
  • GF Score™: 53/100 with 3 warning signs

No single metric tells the full story. See the BSEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

BioStem Technologies Business Description

Address 2836 Center Port Circle, Pompano Beach, FL, USA, 33064
BioStem Technologies Inc is a regenerative biotechnology company focused on harnessing elements of perinatal tissue and the body's innate biology to repair or reverse damage caused by a broad range of degenerative diseases. The company develops, manufactures, and sells tissue allografts for the wound care market with a focus on the treatment of diabetic, pressure, and venous ulcers. Utilizing its proprietary BioRetain processing method, it manufactures perinatal tissue allografts. The company offers a comprehensive portfolio of high-quality brands that are trademarked and include VENDAJE AC, AmnioWrap2, and Others. The company generates key revenue from VENDAJE AC.
53GF Score

Get the complete analysis for BSEM

Interest Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.24
Price
$141.51
GF Value